- Home
- VREX vs RCKT Comparison
VREX vs RCKT Comparison
Compare VREX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- RCKT
- Stock Information
- Founded
- VREX 2016
- RCKT 1999
- Country
- VREX United States
- RCKT United States
- Employees
- VREX N/A
- RCKT N/A
- Industry
- VREX Industrial Machinery/Components
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- VREX Technology
- RCKT Health Care
- Exchange
- VREX Nasdaq
- RCKT Nasdaq
- Market Cap
- VREX 443.9M
- RCKT 328.6M
- IPO Year
- VREX N/A
- RCKT N/A
- Fundamental
- Price
- VREX $11.55
- RCKT $3.28
- Analyst Decision
- VREX Strong Buy
- RCKT Buy
- Analyst Count
- VREX 2
- RCKT 13
- Target Price
- VREX $19.50
- RCKT $12.96
- AVG Volume (30 Days)
- VREX 545.0K
- RCKT 6.0M
- Earning Date
- VREX 08-07-2025
- RCKT 08-07-2025
- Dividend Yield
- VREX N/A
- RCKT N/A
- EPS Growth
- VREX N/A
- RCKT N/A
- EPS
- VREX N/A
- RCKT N/A
- Revenue
- VREX $821,400,000.00
- RCKT N/A
- Revenue This Year
- VREX $5.01
- RCKT N/A
- Revenue Next Year
- VREX $2.97
- RCKT $108.43
- P/E Ratio
- VREX N/A
- RCKT N/A
- Revenue Growth
- VREX N/A
- RCKT N/A
- 52 Week Low
- VREX $6.76
- RCKT $2.19
- 52 Week High
- VREX $16.93
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- VREX 76.25
- RCKT 51.17
- Support Level
- VREX $11.22
- RCKT $2.88
- Resistance Level
- VREX $11.51
- RCKT $3.74
- Average True Range (ATR)
- VREX 0.49
- RCKT 0.27
- MACD
- VREX 0.05
- RCKT 0.02
- Stochastic Oscillator
- VREX 82.53
- RCKT 35.43
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.